Patents by Inventor Inoravadan V. Patel

Inoravadan V. Patel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha
    Patent number: 6319910
    Abstract: Chemically modified tetracyclines are a new class of non-steroidal anti-inflammatory drugs which inhibit cyclooxygenase-2 and tumor necrosis factor alpha. These chemically modified tetracyclines are used in a method for inhibiting COX-2, which in turn inhibits PGE2, and/or inhibiting TNF&agr;. They are also used in a method for treating a disease or disorder associated with elevated activities of COX-2 (i.e., increased production of PGE2) and/or TNF&agr;.
    Type: Grant
    Filed: December 17, 1998
    Date of Patent: November 20, 2001
    Assignee: Hospital for Joint Diseases
    Inventors: Ashok Amin, Steven Abramson, Inoravadan V. Patel